PL2242765T3 - Pochodne polimyksyny o krótkim ogonie z kwasu tłuszczowego i ich zastosowanie - Google Patents

Pochodne polimyksyny o krótkim ogonie z kwasu tłuszczowego i ich zastosowanie

Info

Publication number
PL2242765T3
PL2242765T3 PL09707885T PL09707885T PL2242765T3 PL 2242765 T3 PL2242765 T3 PL 2242765T3 PL 09707885 T PL09707885 T PL 09707885T PL 09707885 T PL09707885 T PL 09707885T PL 2242765 T3 PL2242765 T3 PL 2242765T3
Authority
PL
Poland
Prior art keywords
fatty acid
acid tail
short fatty
polymyxin derivatives
tail polymyxin
Prior art date
Application number
PL09707885T
Other languages
English (en)
Inventor
Martti Vaara
Timo Vaara
Original Assignee
Northern Antibiotics Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI20085110A external-priority patent/FI20085110A0/fi
Application filed by Northern Antibiotics Oy filed Critical Northern Antibiotics Oy
Publication of PL2242765T3 publication Critical patent/PL2242765T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62—Polymyxins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL09707885T 2008-02-08 2009-02-05 Pochodne polimyksyny o krótkim ogonie z kwasu tłuszczowego i ich zastosowanie PL2242765T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6521408P 2008-02-08 2008-02-08
FI20085110A FI20085110A0 (fi) 2008-02-08 2008-02-08 Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä
US12793308P 2008-05-16 2008-05-16
FI20085469A FI20085469A0 (fi) 2008-02-08 2008-05-16 Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä
EP09707885.1A EP2242765B1 (en) 2008-02-08 2009-02-05 Short fatty acid tail polymyxin derivatives and uses thereof

Publications (1)

Publication Number Publication Date
PL2242765T3 true PL2242765T3 (pl) 2017-07-31

Family

ID=39523122

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09707885T PL2242765T3 (pl) 2008-02-08 2009-02-05 Pochodne polimyksyny o krótkim ogonie z kwasu tłuszczowego i ich zastosowanie

Country Status (24)

Country Link
EP (2) EP2242765B1 (pl)
JP (2) JP5752421B2 (pl)
KR (1) KR101627139B1 (pl)
CN (2) CN101970461B (pl)
AU (1) AU2009211287B2 (pl)
BR (1) BRPI0908175B1 (pl)
CA (2) CA2713467C (pl)
CY (1) CY1118625T1 (pl)
DK (1) DK2242765T3 (pl)
ES (1) ES2615813T3 (pl)
FI (1) FI20085469A0 (pl)
HR (1) HRP20170108T1 (pl)
HU (1) HUE031095T2 (pl)
IL (2) IL207275A (pl)
LT (1) LT2242765T (pl)
MX (1) MX2010008674A (pl)
NZ (1) NZ587131A (pl)
PL (1) PL2242765T3 (pl)
PT (1) PT2242765T (pl)
RU (1) RU2492179C2 (pl)
SI (1) SI2242765T1 (pl)
TW (1) TWI383801B (pl)
WO (1) WO2009098357A1 (pl)
ZA (1) ZA201005668B (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20085469A0 (fi) * 2008-02-08 2008-05-16 Northern Antibiotics Oy Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä
BR112014012016A2 (pt) * 2011-11-18 2017-05-16 Cantab Anti-Infectives Ltd compostos
CN102863518B (zh) * 2012-10-09 2014-04-30 湖北美林药业有限公司 一种多粘菌素b化合物及其制备方法
JP6643758B2 (ja) 2013-05-22 2020-02-12 スペロ・セラピューティクス・インコーポレーテッド 異なった抗生物質と一緒の組合せ療法におけるポリミキシン誘導体及びその使用
FR3016888B1 (fr) * 2014-01-27 2021-01-22 Centre Nat Rech Scient Synthetases de la colistine et cluster de genes correspondants
CN107108699A (zh) 2014-11-26 2017-08-29 新药物许可控股有限公司 化合物
US9771394B2 (en) * 2014-12-16 2017-09-26 Micurx Pharmaceuticals, Inc. Antimicrobial polymyxins for treatment of bacterial infections
FI126143B (en) * 2015-01-15 2016-07-15 Northern Antibiotics Oy Polymyxine derivative and its uses
CN109512998A (zh) * 2016-03-04 2019-03-26 广州英赛特生物技术有限公司 含氧碳氢衍生物的酯化衍生物作为多粘菌素的协同增效剂的应用
WO2017189866A1 (en) * 2016-04-27 2017-11-02 Spero Opco Polymyxin analogs useful as antibiotic potentiators
JP2019515007A (ja) * 2016-05-13 2019-06-06 スペロ ポテンシエーター インコーポレイテッドＳｐｅｒｏ Ｐｏｔｅｎｔｉａｔｏｒ， Ｉｎｃ． 新規カチオン性ペプチドｓｐｒ７４１による、抗生物質活性の増強
JP2019519497A (ja) * 2016-05-13 2019-07-11 スペロ ポテンシエーター インコーポレイテッドＳｐｅｒｏ Ｐｏｔｅｎｔｉａｔｏｒ， Ｉｎｃ． Ｓｐｒ７４１のヒト薬物動態及び有効用量
WO2019085926A1 (zh) * 2017-10-31 2019-05-09 上海医药工业研究院 多黏菌素类似物及其制备方法
AU2018359018B2 (en) * 2017-11-02 2022-11-24 The University Of Queensland Peptide antibiotics
MD3810633T2 (ro) 2018-06-25 2024-05-31 Spero Therapeutics Inc Compuşi
CN110179967A (zh) * 2019-05-28 2019-08-30 中国医药集团总公司四川抗菌素工业研究所 多粘菌素母核和一种抗生素的组合物及其应用
US20220265766A1 (en) * 2019-07-30 2022-08-25 The Regents Of The University Of California Antimicrobial therapy through the combination of pore-forming agents and histones
IT201900025414A1 (it) 2019-12-23 2021-06-23 Univ Bologna Alma Mater Studiorum Composto per il trattamento della sindrome emolitico uremica
CN111072757B (zh) * 2020-01-02 2021-10-15 上海上药第一生化药业有限公司 多黏菌素b组分或其盐及其制备方法和应用
JP7045520B2 (ja) 2020-01-02 2022-03-31 上海上薬第一生化薬業有限公司 ポリミキシンｂ成分又はその塩、その製造方法及び使用
EP4125994A4 (en) * 2020-03-25 2024-06-12 Aufbau Medical Innovations Limited METHODS AND MEDICAL TREATMENTS FOR GLAUCOMA
US20220395555A1 (en) * 2020-06-11 2022-12-15 Boris Farber Derivatives of antibiotics
CN118201946A (zh) * 2021-08-12 2024-06-14 奥克兰联合服务有限公司 脂化多粘菌素类似物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450687A (en) 1966-02-24 1969-06-17 Pfizer & Co C Lower alkanoyl esters of polymyxin antibiotics
JPS4915537B1 (pl) 1970-03-25 1974-04-16
US4485039A (en) * 1982-06-11 1984-11-27 University Patents, Inc. Synthetic analogues of α-melanotropin
GB2128617A (en) 1982-10-06 1984-05-02 Martti Vaara Polypeptides for use in antibacterial therapy
US5620955A (en) * 1993-06-18 1997-04-15 Peptide Technologies Corporation Bombesin receptor antagonists and uses thereof
WO2002055543A2 (en) 2001-01-16 2002-07-18 Univ Ramot Hybrid peptides for treatment of bacteremia and septicemia
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
HUE028271T2 (en) * 2006-08-11 2016-12-28 Northern Antibiotics Oy Polymixin derivatives and their applications
FI20085469A0 (fi) * 2008-02-08 2008-05-16 Northern Antibiotics Oy Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä

Also Published As

Publication number Publication date
WO2009098357A1 (en) 2009-08-13
HUE031095T2 (en) 2017-06-28
RU2010135809A (ru) 2012-03-20
FI20085469A0 (fi) 2008-05-16
AU2009211287A1 (en) 2009-08-13
JP6050854B2 (ja) 2016-12-21
IL233430A0 (en) 2014-08-31
TWI383801B (zh) 2013-02-01
HRP20170108T1 (hr) 2017-06-02
CN104086633B (zh) 2018-02-09
CA2979273C (en) 2020-03-24
ZA201005668B (en) 2014-01-29
KR20100130984A (ko) 2010-12-14
EP2242765A1 (en) 2010-10-27
BRPI0908175A2 (pt) 2016-07-05
MX2010008674A (es) 2010-10-04
CN101970461B (zh) 2015-04-08
EP3263586A1 (en) 2018-01-03
CA2713467A1 (en) 2009-08-13
SI2242765T1 (sl) 2017-04-26
TW200936153A (en) 2009-09-01
AU2009211287B2 (en) 2013-08-15
KR101627139B1 (ko) 2016-06-07
DK2242765T3 (en) 2017-02-27
CY1118625T1 (el) 2017-07-12
EP2242765B1 (en) 2017-01-11
CN104086633A (zh) 2014-10-08
LT2242765T (lt) 2017-02-10
NZ587131A (en) 2013-01-25
BRPI0908175B1 (pt) 2021-06-01
PT2242765T (pt) 2017-02-16
CA2979273A1 (en) 2009-08-13
JP2015145399A (ja) 2015-08-13
RU2492179C2 (ru) 2013-09-10
JP2011511045A (ja) 2011-04-07
IL207275A (en) 2015-07-30
JP5752421B2 (ja) 2015-07-22
CA2713467C (en) 2017-11-21
ES2615813T3 (es) 2017-06-08
IL207275A0 (en) 2010-12-30
CN101970461A (zh) 2011-02-09

Similar Documents

Publication Publication Date Title
IL207275A0 (en) Short fatty acid tail polymyxin derivatives and uses thereof
SI2389375T1 (sl) Derivati hidroksamske kisline
EP2445340A4 (en) SUBSTITUTED HYDROXAMINE ACIDS AND USES THEREOF
ZA201203615B (en) Derivatives of 1-amino-2-cyclobutylethylboronic acid
IL218417A0 (en) Fatty acid niacin conjugates and their uses
LT2451437T (lt) Vandeninės kompozicijos, apimančios metioniną
GB0815264D0 (en) Non-cytotoxic proteins
ZA201109034B (en) Aminopyrrolidinone derivatives and uses thereof
IL213974A0 (en) Isoxazole-isoxazole and isoxazole-isothiazole derivatives
ZA201106299B (en) Composition comprising caftaric acid and/or derivatives thereof
IL219264A0 (en) Docetaxel formulations with lipoic acid
ZA201201063B (en) Novel fatty acid desaturases and elongases and uses thereof
ZA201103846B (en) High shear oxidation of wax
EP2408531A4 (en) RINK RAMBARDS WITHOUT HIGH THRESHOLDS
EP2272832A4 (en) PHENYLPROPIONIC ACID DERIVATIVE AND USE THEREOF
EP2542232A4 (en) FATTY ACID INHIBITORS
IL206524A0 (en) 4-dimethylminobutyric acid derivatives
GB2469104B (en) Dynamic rear wing
TWI370821B (en) 18β-glycyrrhetinic acid derivatives and synthetic method thereof
EP2405001A4 (en) NUCLEIC ACID COMPLEX AND NUCLEIC ACID DELIVERING COMPOSITION
PT2307508T (pt) Corantes ácidos
GB0606864D0 (en) Increades fatty acid oxidation
GB0809186D0 (en) Winglet thrust development
GB0607034D0 (en) Increased fatty acid oxidation
IL208372A0 (en) Fatty acid amides and uses thereof